Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure–response modeling of Mayo scores for golimumab in patients with ulcerative colitis
Crossref DOI link: https://doi.org/10.1007/s10928-018-9610-0
Published Online: 2018-10-30
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Chuanpu http://orcid.org/0000-0001-7812-2778
Adedokun, Omoniyi J.
Zhang, Liping
Sharma, Amarnath
Zhou, Honghui
Text and Data Mining valid from 2018-10-30
Article History
Received: 21 June 2018
Accepted: 20 October 2018
First Online: 30 October 2018